Clinical Trial Update: The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the impact of Epogen and Venofer dosing management on hemoglobin stability; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• Epogen (epoetin alfa)
• VENOFER (Iron sucrose)

Snippet

Sponsor: Michael Germain | Conditions: Anemia, End Stage Renal Disease | Phase 4 | Status: TERMINATED